Montelukast sodium

Montelukast sodium
21 August 2026

Montelukast sodium

•    Drug Class: asthma and allergic rhinitis treatment
•    Chemical Formula: C35H35ClNNaO3S
•    CAS Number: 151767-02-1
•    Indications: Montelukast is a leukotriene receptor antagonist indicated for:
-     Prophylaxis and chronic treatment of asthma in patients 12 months of age and older.
-     Acute prevention of exercise-induced bronchoconstriction (EIB) in patients 6 years of age and older.
-    Relief of symptoms of allergic rhinitis (AR): seasonal allergic rhinitis (SAR) in patients 2 years of age and older, and perennial allergic rhinitis (PAR) in patients 6 months of age and older. Reserve use for patients who have an inadequate response or intolerance to alternative therapies
 

Add comment